Notably, the serine400 residue of TPL2 is phosphorylated in a protein kinase B (AKT) dependent manner [24] and the mutational activation of phosphatidylinositol 3-kinase (PI3K)/AKT pathway is common in bladder cancer [33]. This evidence concerns the gene AKT1 and urinary bladder carcinoma.